Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 33NIH 10INDUSTRY 6NETWORK 2UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Rhabdomyosarcoma 5Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Medulloblastoma 4Wilms Tumor 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3Ganglioneuroblastoma 3Central Nervous System Neoplasms 3Burkitt Lymphoma 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Rhabdomyosarcoma, Embryonal 2Rectal Neoplasms 2Oropharyngeal Neoplasms 2Gliosarcoma 2Glioblastoma 2Endometrial Clear Cell Adenocarcinoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Astrocytoma 2Teratoma 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Spinal Cord Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma, Alveolar 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1

Interventions

Carboplatin 33Paclitaxel 28Radiotherapy 23Cisplatin 23Docetaxel 18Gemcitabine 14Pemetrexed 13Radiosurgery 9Bevacizumab 9Magnetic Resonance Spectroscopy 7Etoposide 7Ramucirumab 6Erlotinib Hydrochloride 6Cetuximab 6Specimen Handling 5Gene Expression Profiling 5durvalumab 4cediranib 4Vinorelbine 4Polymerase Chain Reaction 4Amplified Fragment Length Polymorphism Analysis 4pembrolizumab 3cemiplimab 3Watchful Waiting 3Taxes 3Surgical Procedures, Operative 3Radiotherapy, Conformal 3Psychiatric Rehabilitation 3Neoadjuvant Therapy 3Fluorodeoxyglucose F18 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Non-Small-Cell Lung × Radiation × Clear all
NCT02764086 2026-04-13

INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer

Cancer Trials Ireland

Phase 1/2 Terminated
6 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01770418 2025-09-09

A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

Proton Collaborative Group

Phase 1/2 Active not recruiting
32 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡